Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate по Coates, LC, Deodhar, A

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-... по Coates, LC, Mease, P, Kronbergs, A, Helt, C, Sandoval, D, Park, SY, Combe, B, Nash, P, Deodhar, A

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-... по Coates, L, Mease, P, Kronbergs, A, Helt, C, Sandoval, D, Park, SY, Combe, B, Nash, P, Deodhar, A

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial по Helliwell, PS, Mease, PJ, Kavanaugh, A, Coates, LC, Ogdie, A, Deodhar, A, Strand, V, Kricorian, G, Liu, L, Collier, D, Gladman, DD

Guselkumab-treated patients with psoriatic arthritis achieved clinically meaningful improvements in general health outcomes measured with PROMIS-29 through 52 weeks: results from t... по Orbai, AM, Coates, LC, Deodhar, A, Helliwell, P, Ritchlin, CT, Kollmeier, A, Hsia, EC, Xu, XL, Sheng, S, Jiang, Y, Liu, Y, Han, C

Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial по Strand, V, Gossec, L, Coates, LC, Ogdie, A, Choi, J, Becker, B, Zhuo, J, Lehman, T, Nowak, M, Elegbe, A, Mease, PJ, Deodhar, A

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies по Baraliakos, X, Ranza, R, Östör, A, Ciccia, F, Coates, LC, Rednic, S, Walsh, JA, Douglas, K, Gao, T, Kato, K, Song, I-H, Ganz, F, Deodhar, A

Meaningful improvement in general health outcomes with Guselkumab treatment for psoriatic arthritis: Patient-Reported Outcomes Measurement Information System-29 results from a phas... по Orbai, A-M, Coates, LC, Deodhar, A, Helliwell, PS, Ritchlin, CT, Leibowitz, E, Kollmeier, AP, Hsia, EC, Xu, XL, Sheng, S, Jiang, Y, Liu, Y, Han, C

Modulation of interleukin-23 signaling with guselkumab in biologic-naive patients versus tumor necrosis factor inhibitor–inadequate responders with active psoriatic arthritis по Siebert, S, Coates, LC, Schett, G, Raychaudhuri, SP, Chen, W, Gao, S, Seridi, L, Chakravarty, SD, Shawi, M, Lavie, F, Sharaf, M, Zimmermann, M, Kollmeier, AP, Xu, XL, Rahman, P, Mease, PJ, Deodhar, A

Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis по Siebert, S, Coates, LC, Schett, G, Raychaudhuri, SP, Chen, W, Gao, S, Seridi, L, Chakravarty, SD, Shawi, M, Lavie, F, Sharaf, M, Zimmermann, M, Kollmeier, AP, Xu, XL, Rahman, P, Mease, PJ, Deodhar, A

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis по Singh, JA, Guyatt, G, Ogdie, A, Gladman, DD, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, ME, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, PJ, Merola, JF, Miner, J, Ritchlin, CT, Siaton, B, Smith, BJ, Voorhees, AS, Jonsson, AH, Shah, AA, Sullivan, N, Turgunbaev, M, Coates, LC, Gottlieb, A, Magrey, M, Nowell, WB, Orbai, AM, Reddy, SM, Scher, JU, Siegel, E, Siegel, M, Walsh, JA, Turner, AS, Reston, J

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis по Singh, J, Guyatt, G, Ogdie, A, Gladman, D, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, M, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, P, Merola, J, Miner, J, Ritchlin, C, Siaton, B, Smith, B, Van Voorhees, A, Jonsson, A, Shah, A, Sullivan, N, Turgunbaev, M, Coates, L, Gottlieb, A, Magrey, M, Nowell, W, Orbai, A, Reddy, S, Scher, J, Siegel, E, Siegel, M, Walsh, J, Turner, A, Reston, J

Proceedings of the GRAPPA 2022 executive retreat по Ng, B, Jadon, D, Adebajo, A, Ayan, G, Callis Duffin, K, Chandran, V, Coates, LC, D’Agostino, MA, de Vlam, K, Deodhar, A, Eder, L, Garg, A, Gladman, DD, Goel, N, Gottlieb, A, Husni, ME, Katz, A, Kavanaugh, A, Lubrano, E, Mease, P, Merola, J, Nash, P, Ogdie, A, Pennington, S, Perez-Chada, LM, Proft, F, Rosen, CF, Savage, L, Goldenstein-Schainberg, C, Siebert, S, Soriano, E, Steinkoenig, I, Tillett, W, Armstrong, A, FitzGerald, O

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis по Singh, J, Guyatt, G, Ogdie, A, Gladman, D, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, M, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, P, Merola, J, Miner, J, Ritchlin, C, Siaton, B, Smith, B, Van Voorhees, A, Jonsson, A, Shah, A, Sullivan, N, Turgunbaev, M, Coates, L, Gottlieb, A, Magrey, M, Nowell, W, Orbai, A, Reddy, S, Scher, J, Siegel, E, Siegel, M, Walsh, J, Turner, A, Reston, J